New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines
Author:
Funder
Regeneron
Sanofi Aventis
MedImmune
Celgene
Stiefel/GlaxoSmithKline
Celsus
BMS
Amgen
Drais
AbbVie
Anacor
AnaptysBio
Dermira
Galderma
Leo Pharma
Novartis
Pfizer
Vitae
Mitsubishi Tanabe
Eli Lilly
Glenmark
Asana Biosciences
Janssen
Merck
UCB
Sanofi Israel
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology
Reference110 articles.
1. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: a systematic review and meta-analysis;Ronnstad;J Am Acad Dermatol,2018
2. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients;Wollenberg;J Eur Acad Dermatol Venereol,2016
3. An integrated model of atopic dermatitis biomarkers highlights the systemic nature of the disease;Ungar;J Invest Dermatol,2017
4. Atopic dermatitis in America study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population;Chiesa Fuxench;J Invest Dermatol,2019
5. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II;Wollenberg;J Eur Acad Dermatol Venereol,2018
Cited by 103 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unravelling the Complexities and Recent Advances in the Management of Atopic Dermatitis;Current Drug Therapy;2024-08-08
2. Atopic Dermatitis and Psoriasis: Similarities and Differences in Metabolism and Microbiome;Clinical Reviews in Allergy & Immunology;2024-07-02
3. Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis: Mechanistic considerations;Journal of Allergy and Clinical Immunology;2024-07
4. Integrating multi‐omics approaches in deciphering atopic dermatitis pathogenesis and future therapeutic directions;Allergy;2024-06-04
5. Effectiveness and safety of systemic therapy for moderate-to-severe atopic dermatitis in children and adolescent patients: a systematic review;Frontiers in Immunology;2024-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3